Fasenra Pen 30 mg /1 ml, lnjektionslösung in einem Fertigpen

7680675810017 CH-67581 Fertigpen
Fasenra Pen 30 mg /1 ml, lnjektionslösung in einem Fertigpen
Fasenra Pen 30 mg /1 ml, lnjektionslösung in einem Fertigpen
Fasenra Pen 30 mg /1 ml, lnjektionslösung in einem Fertigpen
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/11/2024
Patient information leaflet
Français
04/11/2024
Patient information leaflet
Italien
04/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2538.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2020

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
67581
Drug name
Fasenra Pen, Injektionslösung in einem Fertigpen
Galenic form
INLFP
ATC Code
R03DX10
Authorization status
Z
Dispensing category
B
First authorization
18/05/2020
Authorization expiration date
31/12/9999
IT Number
03.04.5.
Domain
Human medicine
Field of application
Schweres eosinophiles Asthma, EGPA

Package details

Description (FR)
FASENRA Pen sol inj 30 mg/ml stylo pré 1 ml
Description (DE)
FASENRA Pen Inj Lös 30 mg/ml Fertpen 1 ml
Market launch
18/05/2020
Narcotic (BTM)
No